Los CFD son instrumentos complejos y están asociados a un riesgo elevado de perder dinero rápidamente debido al apalancamiento. 79% de las cuentas de inversores minoristas pierden dinero en la comercialización con CFD con este proveedor. Debe considerar si comprende el funcionamiento de los CFD y si puede permitirse asumir un riesgo elevado de perder su dinero.

DISCLAIMER

Our systems have detected that you are using a computer with an IP address located in the USA. If you are currently not located in the USA, please click “Continue” in order to access our Website.

Local restrictions - provision of cross-border services

Swissquote Ltd is authorised and regulated in the UK by the Financial Conduct Authority (FCA). Swissquote Ltd is not authorised by any US authority (such as the CFTC or SEC) neither is it authorised to disseminate offering and solicitation materials for offshore sales of securities and investment services, to make financial promotion or conduct investment or banking activity in the USA whatsoever.

This website may however contain information about services and products that may be considered by US authorities as an invitation or inducement to engage in investment activity having an effect in the USA.

By clicking “Continue”, you confirm that you have read and understood this legal information and that you access the website on your own initiative and without any solicitation from Swissquote Ltd.

If cookies are currently disabled on your computer, you will be required to continue accepting this legal information for every new page visited on this website. In order to avoid this, please enable cookies on your computer.

Research Market strategy
by Swissquote Analysts
Las bolsas de Asia iniciaron la semana con una nota positiva fuerte; las esperanzas de obtener más apoyo de la política son prácticamente la única explicación para el optimismo inicial de la semana.El índice compuesto de Shanghái subi...
06.07.2020
Los índices estadounidenses cerraron mayormente en alza el miércoles por la promesa del ensayo de una vacuna de Pfizer y BioNTech para el Covid, que mantuvo la esperanza de tener una vacuna para enero y disminuyó las preocupaciones co...
02.07.2020
 
Live chat